Cognizin Ingredient Shown to Improve Focus, Concentration and Memory

26 Jan 2011 --- A six-week study conducted at McLean Hospital, a Harvard Medical School affiliate located in Belmont, Mass., was designed to measure and visualize the functional effects of Cognizin on various facets of brain function.

1/26/2011 --- Deborah Yurgelun-Todd, Ph.D., Director of the Cognitive Neuroimaging Laboratory at The Brain Institute at The University of Utah, presented new scientific data on Kyowa Hakko's branded brain health ingredient Cognizin at the SupplySide Science Tour held January 24, 2011, in Irvine, Calif. She highlighted results of a six-week study conducted at McLean Hospital, a Harvard Medical School affiliate located in Belmont, Mass., designed to measure and visualize the functional effects of Cognizin on various facets of brain function.

On the first day of testing, 16 healthy subjects aged 40 - 60 years underwent functional Magnetic Resonance Imaging (fMRI) while completing both the Stroop task, which is designed to measure attention and reaction time, and the Morris Water Maze task, which examines spatial memory. Subjects were then given a daily oral dose of either 500 or 2000 mg of Cognizin for six weeks before a second imaging protocol was conducted.

After completion of the second fMRI imaging test, increased activation was seen during completion of the Stroop interference task. This was accompanied by improved accuracy in generating correct responses. 

These results indicated that use of Cognizin resulted in a better, more accurate performance, accompanied by increased brain metabolism. 
Increased activation was seen during completion of the second Water Maze test as well. This was accompanied by increased time spent in the correct quadrant. These results indicated that use of Cognizin resulted in better spatial memory retrieval, in addition to increased brain metabolism. Results were nearly identical for individuals receiving 500 mg and 2000 mg of Cognizin, confirming that statistically significant improvements in attention, focus, memory and recall can be achieved at dosing levels of 500 mg.

"Neuroimaging data demonstrated increased regional brain activation, which was related to increased concentration, greater ability to focus and improved accuracy on cognitive tasks after subjects received Cognizin," noted Dr. Yurgelun-Todd. "Greater performance on a spatial memory task was also observed."

Cognizin Citicoline is a natural, water-soluble brain health ingredient, and is a well-established part of the cognitive health category. Vast research indicates this safe and effective branded compound helps protect neural tissue from free radical damage. It also supports brain performance by enhancing metabolism and healthy activity. Unlike other single-action ingredients for brain health, Cognizin is multi-functional. It has shown to benefit individuals affected by memory loss, mood/behavioral disorders, mild cognitive impairment and certain vision disorders.

Related Articles

Nutrition & Health News

Special Report: Bone Health Supplementation Moves Beyond Dairy

22 May 2017 --- Bone health is becoming an increasingly researched topic, particularly as populations around the globe are becoming more aged. Consuming dairy products for strong bones has long been encouraged by governments and parents alike. However, as consumer preferences change, there is a growing need for non-dairy supplementation that can improve bone density. According to Innova Market Insights data, the number of product launches featuring bone health claims rose drastically from 364 in 2015, to 571 in 2016. NutritionInsight looks at some of the most recent bone health related product launches and studies.

Business News

Scientists Urge US Government to Meet Compliance Deadline for Nutrition Labels

22 May 2017 --- As US food industry groups continue to urge the government to delay the July 2018 compliance date for the updated nutrition facts label, consumer advocacy group and non-profit watchdog Center for Science in the Public Interest (CSPI) claims that more than 40 scientists and researchers from across the country are calling for the date to stand.

Business News

No Such Thing as “Healthy Obesity”: Study

22 May 2017 --- “Healthy” obese people are still at higher risk of heart failure or stroke than the general population, according to research by scientists at the University of Birmingham. The results indicate that the concept of “healthy obesity” – a condition characterized by having normal markers of metabolic health despite a body mass index (BMI) of 30 or more – is, in fact, a myth.

Nutrition & Health News

Neuroimaging Highlights Role of Omega 3 in Preventing Cognitive Decline

22 May 2017 --- Research involving neuroimaging has shown that people with higher omega 3 levels have increased blood flow in regions of the brain associated with memory and learning, according to a report in the Journal of Alzheimer’s Disease. With the incidence of Alzheimer’s disease (AD) expected to triple in the coming decades, interest in dietary approaches for the prevention of cognitive decline has increased. In particular, the omega 3 fatty acids have shown anti-amyloid, anti-tau and anti-inflammatory actions in the brains of animals. 

 

Business News

Grilling or Microwaving Best Ways to Preserve Nutritional Value of Mushrooms

22 May 2017 --- A study by Spanish researchers has shown that microwaving and grilling are the best way to prepare mushrooms in terms of maintaining their nutritional profile. Mushrooms are considered valuable health foods, since they have a significant amount of dietary fiber and are poor in calories and fat. Moreover, they have a good protein content (20-30% of dry matter) which includes most of the essential amino acids.

More Articles
URL : http://www.nutritioninsight.com:80/news/Cognizin-Ingredient-Shown-to-Improve-Focus-Concentration-and-Memory.html